Humacyte (HUMA) News Today → Just Released: Insider's Secret to Trading Options (From Schaeffer’s Research) (Ad) Free HUMA Stock Alerts $3.82 -0.11 (-2.80%) (As of 04/24/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineA U.S. Senator Just Bought this Tiny Stock – It’s Up 15% Todaymsn.com - April 20 at 2:59 PMA U.S. Senator Just Bought this Tiny Stock - It's Up 15% Todaymsn.com - April 18 at 7:56 PMAlly Financial Reports Upbeat Earnings, Joins Badger Meter, Genuine Parts And Other Big Stocks Moving Higher On Thursdaybenzinga.com - April 18 at 2:55 PMTuberville’s Trading Raises Questions: Senator Sells Put Options, Invests in Small Biotech Tied to Ukraine-Russia Conflictmsn.com - April 18 at 2:55 PMShort Interest in Humacyte, Inc. (NASDAQ:HUMA) Expands By 5.3%americanbankingnews.com - April 18 at 4:28 AMU.S. Senator Tommy Tuberville Just Reported a Purchase of $HUMA stockca.investing.com - April 17 at 11:14 PMHumacyte, Inc. (HUMA) Interactive Stock Chart - Yahoo Financefinance.yahoo.com - April 15 at 11:26 PMOppenheimer Keeps Their Buy Rating on Humacyte (HUMA)markets.businessinsider.com - April 8 at 4:08 PMResearch Analysts Set Expectations for Humacyte, Inc.'s FY2024 Earnings (NASDAQ:HUMA)marketbeat.com - April 4 at 9:14 AMHumacyte's (HUMA) Overweight Rating Reiterated at Cantor Fitzgeraldmarketbeat.com - April 1 at 9:10 AMShort Interest in Humacyte, Inc. (NASDAQ:HUMA) Declines By 36.5%marketbeat.com - March 29 at 10:48 AMHumacyte to Host Virtual KOL Event “Hemodialysis Access: A Crossroads of Care,” on March 28, 2024globenewswire.com - March 26 at 4:05 PMHumacyte's (HUMA) "Buy" Rating Reiterated at Benchmarkmarketbeat.com - March 25 at 12:21 PMHumacyte’s Strong Outlook: Buy Rating Affirmed Amid Advancements and Market Opportunitymarkets.businessinsider.com - March 23 at 6:39 PMQ4 2023 Humacyte Inc Earnings Callfinance.yahoo.com - March 23 at 8:42 AMHumacyte (NASDAQ:HUMA) Posts Earnings Resultsmarketbeat.com - March 23 at 8:26 AMBuy Rating for Humacyte: Anticipated FDA Approval and Strong Financials Signal Growth Potentialmarkets.businessinsider.com - March 22 at 10:41 PMHUMA Stock Earnings: Humacyte Meets EPS for Q4 2023investorplace.com - March 22 at 11:53 AMHumacyte GAAP EPS of -$0.24 in-linemsn.com - March 22 at 10:12 AMHumacyte Fourth Quarter and Year End 2023 Financial Results and Business Updateglobenewswire.com - March 22 at 7:00 AMWhat Wall Street expects from Humacyte's earningsmarkets.businessinsider.com - March 21 at 7:10 PMHumacyte (HUMA) to Release Quarterly Earnings on Fridaymarketbeat.com - March 19 at 10:05 AMHumacyte, Inc. (NASDAQ:HUMA) Sees Large Drop in Short Interestmarketbeat.com - March 18 at 9:57 PMHumacyte to Present 2023 Fourth Quarter and Year-End Financial Results and Provide Corporate Update on March 22, 2024globenewswire.com - March 18 at 8:00 AMHUMA Apr 2024 5.000 callca.finance.yahoo.com - March 18 at 12:54 AMHumacyte Shares Rise 10% on Common Stock Offeringmarketwatch.com - March 4 at 3:37 PMWhy Humacyte (HUMA) Shares Are Fallingmsn.com - March 1 at 2:07 PMHumacyte, Inc. to Present at the TD Cowen 44th Annual Health Care Conferenceglobenewswire.com - March 1 at 9:16 AMHumacyte stock dips after pricing stock offering to raise $40.2Mmsn.com - March 1 at 8:56 AMHumacyte Shares Drop 19% After Proposed Public Offering Newsmarketwatch.com - February 29 at 11:02 PMHumacyte, Inc. Announces Pricing of $40.2 Million Public Offering of Common Stockglobenewswire.com - February 29 at 9:18 PMHumacyte, Inc. Announces Proposed Public Offering of Common Stockglobenewswire.com - February 29 at 4:01 PMHere's Why We're Watching Humacyte's (NASDAQ:HUMA) Cash Burn Situationfinance.yahoo.com - February 26 at 10:02 AMBCTX Jul 2024 2.500 putfinance.yahoo.com - February 23 at 12:18 PMIMGN Mar 2024 32.000 put(CONTRAfinance.yahoo.com - February 17 at 8:28 AMHUMA Mar 2024 5.000 putfinance.yahoo.com - February 17 at 8:28 AMIMGN Jul 2024 29.000 callfinance.yahoo.com - February 15 at 9:27 AMHUMA Mar 2024 2.500 callfinance.yahoo.com - February 14 at 8:30 AMIMGN Apr 2024 18.000 putfinance.yahoo.com - February 14 at 1:39 AMBuy Rating Justified by FDA Review and Commercial Prospects for Humacyte’s HAV Devicemarkets.businessinsider.com - February 9 at 6:49 PMHumacyte Shares Rise After FDA Grants Priority Review to Vascular Trauma Treatmentmarketwatch.com - February 9 at 6:49 PMHumacyte Gets Speedy FDA Review of Bioengineered Tissue in Vascular Traumamarketwatch.com - February 9 at 8:47 AMHumacyte: FDA Grants Priority Review To BLA Seeking Approval Of Human Acellular Vesselmarkets.businessinsider.com - February 9 at 8:47 AMHuman Acellular Vessel™ (HAV™) Biologics License Application Granted Priority Review by U.S. FDA for the Treatment of Vascular Traumafinance.yahoo.com - February 9 at 8:47 AMMarket Gets Ugly as Traders Resist Blindly Chasing Big Techrealmoney.thestreet.com - February 6 at 1:41 AMDurham public company hiring ahead of potential product launchbizjournals.com - January 23 at 9:35 AMHumacyte, Inc.'s (NASDAQ:HUMA) largest shareholders are retail investors with 48% ownership, public companies own 18%finance.yahoo.com - January 16 at 3:58 PMHumacyte, Inc. (NASDAQ:HUMA) Sees Large Increase in Short Interestmarketbeat.com - January 15 at 11:48 AMShort Interest in Humacyte, Inc. (NASDAQ:HUMA) Decreases By 5.3%marketbeat.com - January 3 at 7:21 AMHumacyte (NASDAQ:HUMA) PT Lowered to $15.00marketbeat.com - December 27 at 2:33 PM Get Humacyte News Delivered to You Automatically Sign up to receive the latest news and ratings for HUMA and its competitors with MarketBeat's FREE daily newsletter. Email Address Just Released: Insider's Secret to Trading Options (Ad)This Surprisingly Simple Formula Can Double Your Money Collecting Consistent Profits From The Stock Market Is More Accessible Than You Think A small group of individuals are using a legitimate yet rarely discussed strategy to generate income from the stock market. They're NOT day traders. And they're NOT Wall Street suits either. I'm talking about normal "working stiffs" and retirees generating steady income from a source that 99% of investors completely overlook. This overlooked income source can be yours today. Yes! Show Me This Strategy HUMA Media Mentions By Week HUMA Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HUMA News Sentiment▼0.110.43▲Average Medical News Sentiment HUMA News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HUMA Articles This Week▼42▲HUMA Articles Average Week Get Humacyte News Delivered to You Automatically Sign up to receive the latest news and ratings for HUMA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: TSHA News Today CCCC News Today EDIT News Today ALEC News Today FATE News Today ALVO News Today VYGR News Today EXAI News Today LXEO News Today VALN News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:HUMA) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyThe #1 Crypto for 2024InvestorPlaceEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsFed launches fourth dollar overhaulStansberry ResearchUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American Alternative1970’s computer coder issues shocking A.I. warningTradeSmith Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Humacyte, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
